Redcare Pharmacy stock traded at EUR 132 per share at the end 2024 translating into a market capitalization of USD 2,740 mil. Since the end of 2019, the stock has appreciated by 203% representing an annual average growth of 24.8%.
At the end of 2024, the firm traded at price to earnings of -58.0x. Over the last five years, this multiple achieved a high of -10.2x in 2022 and a low of -180x in 2023 with an average of -78.2x.
Regarding cash generated defined by the sum of net profit and depreciation, the stock traded at -96.4x at the end of 2024. When investments are excluded to get free cash flow, Redcare Pharmacy traded at 123x.
At the end of 2024, the company had a net debt of EUR 69.8 mil, or 2.39x of EBITDA and 13.7% of equity. The firm generated an average return on equity of -10.9% for its shareholders in the last five years and an average dividend yield of 0%.
You can see all the company’s data at Redcare Pharmacy profile, or you can download a report on the company in the report section.
Helgi Library 
